http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009079679-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a9d0302e4c3c3bbe4633849b07efc4b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd928b5c64cf0e30e2925ad47ed996b4
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6951
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-724
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-724
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
filingDate 2008-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8588935643e58066a3bb8c280953af56
publicationDate 2009-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2009079679-A2
titleOfInvention Pharmaceutical composition
abstract The present invention relates to a pharmaceutical composition in the form of a storage-stable solution for the parenteral administration of ultrashort-effective ß-adrenoreceptor antagonists, comprising a) an ultrashort-effective ß-adrenoreceptor antagonist and/or a pharmaceutically acceptable salt thereof, b) water, and c) a cyclodextrin and/or a functional cyclodextrin derivative. The composition according to the invention has high stability, even without the presence of additional adjuvants.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013167657-A1
priorityDate 2007-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396153
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444913
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5287407
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66587026
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399874
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226913612
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426192
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25271656
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID114905
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104769
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID55885
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59768
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226492913
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28125476
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID157716
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395793
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4171
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4911
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226492914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426193
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9914270
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226493024
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395751

Total number of triples: 57.